“…18,19 cART could also prevent new non-AIDS events since it has been reported that patients with higher level of CD4 T cell and controlled viral replication have lower rates of death and non-AIDS events. 1,3,7,8,11,20,21 In fact, it has been reported in the SMART study 22 that patients who discontinued cART had a higher risk of non-AIDS events and death than patients who continued with medication. It is also known that patients who started cART with a high level of CD4 T cell count had a lower risk of death than patients who delay the initiation of medication.…”